CN100522940C - 用于治疗对PPARα活化有反应的疾病的α-苯硫基羧酸和α-苯氧基-羧酸的衍生物 - Google Patents

用于治疗对PPARα活化有反应的疾病的α-苯硫基羧酸和α-苯氧基-羧酸的衍生物 Download PDF

Info

Publication number
CN100522940C
CN100522940C CNB038022893A CN03802289A CN100522940C CN 100522940 C CN100522940 C CN 100522940C CN B038022893 A CNB038022893 A CN B038022893A CN 03802289 A CN03802289 A CN 03802289A CN 100522940 C CN100522940 C CN 100522940C
Authority
CN
China
Prior art keywords
thiophenyl
methyl isobutyrate
oxyethyl group
methyl
isobutyrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB038022893A
Other languages
English (en)
Chinese (zh)
Other versions
CN1620429A (zh
Inventor
F·詹尼斯
N·德吕穆
E·塔松尼
M·O·坦迪
A·F·夏尔罗尼
M·邦德拉
P·佩松托
A·阿杜尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of CN1620429A publication Critical patent/CN1620429A/zh
Application granted granted Critical
Publication of CN100522940C publication Critical patent/CN100522940C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
CNB038022893A 2002-01-15 2003-01-15 用于治疗对PPARα活化有反应的疾病的α-苯硫基羧酸和α-苯氧基-羧酸的衍生物 Expired - Fee Related CN100522940C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM02A000014 2002-01-15
IT2002RM000014A ITRM20020014A1 (it) 2002-01-15 2002-01-15 Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del

Publications (2)

Publication Number Publication Date
CN1620429A CN1620429A (zh) 2005-05-25
CN100522940C true CN100522940C (zh) 2009-08-05

Family

ID=11455954

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038022893A Expired - Fee Related CN100522940C (zh) 2002-01-15 2003-01-15 用于治疗对PPARα活化有反应的疾病的α-苯硫基羧酸和α-苯氧基-羧酸的衍生物

Country Status (16)

Country Link
US (2) US20050054671A1 (enExample)
EP (1) EP1474387B1 (enExample)
JP (1) JP2005514456A (enExample)
KR (1) KR100975961B1 (enExample)
CN (1) CN100522940C (enExample)
AR (1) AR038146A1 (enExample)
AT (1) ATE489361T1 (enExample)
AU (1) AU2003209679B2 (enExample)
BR (1) BR0306824A (enExample)
CA (1) CA2472223A1 (enExample)
DE (1) DE60335083D1 (enExample)
IT (1) ITRM20020014A1 (enExample)
MX (1) MXPA04006803A (enExample)
PL (1) PL372666A1 (enExample)
TW (1) TW200305410A (enExample)
WO (1) WO2003059875A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553867B2 (en) 2002-09-06 2009-06-30 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
ITRM20020629A1 (it) * 2002-12-19 2004-06-20 Sigma Tau Ind Farmaceuti Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
DK1667964T3 (da) 2003-09-19 2009-10-26 Janssen Pharmaceutica Nv 4-((Phenoxyalkyl)thio)-phenoxyeddikesyrer og analoger
CN1867546A (zh) * 2003-10-28 2006-11-22 雷迪实验室有限公司 新颖化合物及其在药物中的用途、其制备方法以及含有它们的药物组合物
US7902367B2 (en) 2004-08-11 2011-03-08 Kyorin Pharmaceutical Co., Ltd. Cyclic amino benzoic acid derivative
MY147518A (en) * 2004-09-15 2012-12-31 Janssen Pharmaceutica Nv 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
FR2880886B1 (fr) * 2005-01-14 2007-04-06 Merck Sante Soc Par Actions Si Derives de l'acide 6-phenylhex-5-enoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
WO2006082495A1 (en) * 2005-02-02 2006-08-10 Ranbaxy Laboratories Limited Peroxisome proliferator activated receptor modulators
FR2882359A1 (fr) * 2005-02-24 2006-08-25 Negma Lerads Soc Par Actions S Derives activateurs de ppar, procede de preparation et application en therapeutique
WO2006101108A1 (ja) * 2005-03-23 2006-09-28 Kyorin Pharmaceutical Co., Ltd. 新規環状アミノフェニルアルカン酸誘導体
JO3006B1 (ar) 2005-09-14 2016-09-05 Janssen Pharmaceutica Nv املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
PE20080188A1 (es) 2006-04-18 2008-03-10 Janssen Pharmaceutica Nv Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol
WO2008014430A1 (en) 2006-07-27 2008-01-31 Emisphere Technologies, Inc. Arylsulfanyl compounds and compositions for delivering active agents
JP5305818B2 (ja) * 2008-10-03 2013-10-02 キヤノン株式会社 生体情報取得装置
JP5669889B2 (ja) * 2013-06-27 2015-02-18 キヤノン株式会社 生体情報取得装置
CN106179111B (zh) * 2016-07-16 2018-08-14 江南大学 一种由羧酸盐阴离子表面活性剂和二聚季铵盐形成的粘弹溶液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
US3663540A (en) * 1970-06-19 1972-05-16 R & L Molecular Research Ltd 7 - (p-aminomethylphenylthio)acetamido-3 -(pyridiniummethyl)ceph - 3 - em - 4-carboxylate
US3965093A (en) * 1971-09-24 1976-06-22 E. R. Squibb & Sons, Inc. 6-Arylthio penicillanic acid and derivatives thereof
GB1422679A (en) * 1972-11-16 1976-01-28 Funai Pharmaceutical Ind Ltd Substituted phenoxy-a-methylpropionic acid derivatives and a process for producing the same
FR2285867A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Derives du diphenylsulfoxyde
DE2861187D1 (en) * 1977-07-07 1981-12-24 Ciba Geigy Ag Phenoxy-phenylsulfinyl-and-sulfonylalkanecarboxylic acid derivatives, method for their preparation and their use as herbicides and plant growth regulators.
JPH0311045A (ja) * 1989-06-08 1991-01-18 Hodogaya Chem Co Ltd ベンズアミド誘導体
JPH06234732A (ja) * 1992-09-10 1994-08-23 Banyu Pharmaceut Co Ltd 置換アセトアミド誘導体
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
JP3583529B2 (ja) * 1995-12-04 2004-11-04 富士写真フイルム株式会社 ハロゲン化銀感光材料
EP0904079B1 (en) * 1996-02-02 2004-03-24 Merck & Co., Inc. Antidiabetic agents
AU4050797A (en) 1996-08-02 1998-02-25 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
US6197791B1 (en) * 1997-02-27 2001-03-06 American Cyanamid Company N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6294573B1 (en) * 1997-08-06 2001-09-25 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
CA2335288A1 (en) * 1998-06-22 1999-12-29 F. Hoffmann-La Roche Ag Propenyl cephalosporin derivatives
JP4618845B2 (ja) * 1999-06-09 2011-01-26 杏林製薬株式会社 ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体
DE19940415A1 (de) * 1999-08-26 2001-03-08 Friedrich Spener Verzweigtkettige Fettsäuren als fettabbauende Wirkstoffe
US6525093B1 (en) * 1999-11-08 2003-02-25 Calyx Therapeutics Inc. Compounds to treat diabetes and associated conditions
KR20020090211A (ko) * 2000-01-28 2002-11-30 노보 노르디스크 에이/에스 알키닐 치환된 프로피온산 유도체 및 당뇨병 및 비만에대한 그것의 사용
WO2001079150A1 (en) * 2000-04-17 2001-10-25 Novo Nordisk A/S New compounds, their preparation and use
PT1285908E (pt) * 2000-05-29 2008-12-04 Kyorin Seiyaku Kk Derivados do ácido fenilpropiónico substituídos
CA2420178A1 (en) * 2000-08-23 2002-03-07 Eli Lilly And Company Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
GB0111523D0 (en) * 2001-05-11 2001-07-04 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
DE60335083D1 (de) 2011-01-05
CN1620429A (zh) 2005-05-25
US20080027098A1 (en) 2008-01-31
KR100975961B1 (ko) 2010-08-16
AR038146A1 (es) 2004-12-29
ATE489361T1 (de) 2010-12-15
EP1474387A2 (en) 2004-11-10
TW200305410A (en) 2003-11-01
WO2003059875A3 (en) 2003-12-04
AU2003209679A1 (en) 2003-07-30
EP1474387B1 (en) 2010-11-24
BR0306824A (pt) 2004-12-21
KR20040068996A (ko) 2004-08-02
ITRM20020014A1 (it) 2003-07-15
US20050054671A1 (en) 2005-03-10
WO2003059875A2 (en) 2003-07-24
JP2005514456A (ja) 2005-05-19
AU2003209679B2 (en) 2009-02-19
PL372666A1 (en) 2005-07-25
ITRM20020014A0 (it) 2002-01-15
CA2472223A1 (en) 2003-07-24
MXPA04006803A (es) 2004-10-11
HK1076625A1 (zh) 2006-01-20

Similar Documents

Publication Publication Date Title
CN100522940C (zh) 用于治疗对PPARα活化有反应的疾病的α-苯硫基羧酸和α-苯氧基-羧酸的衍生物
CN101772487B (zh) 甲状腺类化合物
TWI249522B (en) Compounds that modulate PPAR activity and methods for their preparation
AU721452B2 (en) Antidiabetic agents
CN101679250A (zh) Ppar活性化合物
KR20090118958A (ko) Ｐｐａｒ 활성 화합물
SG187176A1 (en) Agonists of gpr40
MXPA04008176A (es) Derivado de acido fenilalcanoico sustituido y uso del mismo.
US10508090B2 (en) Sulfonamides as GPR40- and GPR120-agonists
CS223842B2 (en) Method of making the pyridoxin derivatives
CA2472209A1 (en) Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
CN100393309C (zh) 具有降低血清葡萄糖和降低血清脂质活性的α-苯硫基羧酸和α-苯氧基羧酸的用途
WO2000023442A1 (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
WO2001027088A1 (en) Lpl potentiators
HK1076625B (en) Derivatives of a-phenylthiocarboxylic and sg(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppara activation
JPWO2018159650A1 (ja) グアニジン誘導体及びその医薬用途
CA2144293C (en) Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases
JP2007512263A (ja) 化学的脱共役剤として使用するためのインドール誘導体
JP4220827B2 (ja) 安息香酸誘導体及びこれを含有する医薬
HK1087007B (en) Use of a-phenylthiocarboxylic and a-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
WO2005100318A1 (en) Alkanoic acids and their esters as antidiabetic agents
EP1214301A1 (en) Hypoglycemic n,n-arylsulfonylglycine compounds
JP2017081888A (ja) 新規な化合物、薬剤およびｎｋ３受容体拮抗剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1076625

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1076625

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090805

Termination date: 20110115